“Sourdough is the only bread that lowers blood sugar instead of spiking it, improves nutrient absorption instead of blocking it, and feeds gut bacteria so the body can thrive." Supporting post text adds: fermentation microbes "consume the starches and sugars before you even take a bite," lactic acid keeps "blood sugar totally balanced,"…”

**Sub-claim 1: blood sugar.** The 2024 systematic review and meta-analysis of 18 clinical trials found that sourdough bread produced a smaller rise in blood glucose than industrial bread or glucose, with a mean difference of -0.29 mmol/L at 60 minutes and -0.21 mmol/L at 120 minutes. The authors state the effect is strongest when the bread is made with whole wheat flour, that sourdough did not reduce fasting serum insulin, and critically that **the certainty of the evidence ranged from low to very low**. The Korem 2017 randomized crossover trial in 20 healthy adults compared industrial white bread with artisanal whole-wheat sourdough and found **no significant difference** in clinical effects between the two breads, with gut microbiome composition remaining generally stable. Glycemic responses to each bread were highly individual and predictable from baseline microbiome profile. Mofidi et al. tested five breads head-to-head in overweight and obese men. When matched by bread mass, glucose and insulin area-under-curve for **sourdough was greater than for 11-grain, sprouted-grain, and 12-grain breads**. Sprouted-grain bread, not sourdough, produced the best glycemic profile. Published GI values place sourdough wheat bread at 54 and sourdough rye at 48, while pumpernickel/rye kernel bread ranges 41 to 56 and 100% whole grain rye and barley breads are commonly listed lower still. Jenkins' human testing found pumpernickel at GI 78 and whole wheat kernel bread at 63 on the white-bread scale, both below wholemeal wheat bread at 96. **Sub-claim 2: phytic acid.** Lopez et al. found sourdough fermentation reduced phytate in whole wheat bread by **62%**, compared with 38% for yeast fermentation. Leenhardt et al. found acidification to pH 5.5 produced **70%** phytate breakdown versus 40% without leavening. Reduction is substantial but partial, not elimination. On whether this translates into actual human nutrient benefit, the 2026 Frontiers systematic review of 8 human intervention studies concluded that despite mechanistic evidence, **"no human studies address this research question with the appropriate control and study quality."** Acute postprandial studies showed increased non-heme iron bioavailability, but long-term trials did not improve iron status and in one case worsened it: in a low-phytate sourdough rye bread group, ferritin fell from 32 to 27 µg/L and total body iron from 6.9 to 5.4 mg/kg over 12 weeks. The reviewers called the human evidence limited, heterogeneous, and inconclusive. **Sub-claim 3: gut microbiome.** The 2024 Pérez-Vega RCT in subjects with metabolic syndrome found **no differences in microbiota richness or abundance**, and longer fermentation times provided no additional benefit. It did find lower PAI-1 and reduced sICAM with the short-fermentation bread, suggesting a possible inflammation-marker effect. That paper also notes a two-month ulcerative colitis trial (n=23) reporting no microbiota diversity differences, and a one-week trial in 20 healthy subjects comparing sourdough to white bread that found no differences in alpha or beta diversity or phylum-level abundances. Korem 2017 similarly found the microbiome generally stable. ---